The November issue explores how #genomic medicine is expanding across healthcare systems, #biobanking, collaborative platforms, and patient-centred perspectives. 🧬
www.nature.com/ejhg/volumes...
#Genetics #RareDisease
www.nature.com/articles/s41...
#Genetics #RareDisease
www.nature.com/articles/s41...
#Genetics #RareDisease
www.nature.com/articles/s41...
#Genetics #RareDisease
www.nature.com/articles/s41...
www.nature.com/articles/s41...
www.nature.com/articles/s41...
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Forty novel variants were identified, supporting #WES and parental testing for early intervention. 🧬
www.nature.com/articles/s41...
Forty novel variants were identified, supporting #WES and parental testing for early intervention. 🧬
www.nature.com/articles/s41...
Forty novel variants were identified, supporting #WES and parental testing for early intervention. 🧬
www.nature.com/articles/s41...
Forty novel variants were identified, supporting #WES and parental testing for early intervention. 🧬
www.nature.com/articles/s41...
Read more ⬇️
www.nature.com/articles/s41...
Read more ⬇️
www.nature.com/articles/s41...
Read more ⬇️
www.nature.com/articles/s41...
Read more ⬇️
www.nature.com/articles/s41...
A unique DNA methylation episignature may help reclassify #VUS and refine diagnosis. 🧬
🔗 www.nature.com/articles/s41...
A unique DNA methylation episignature may help reclassify #VUS and refine diagnosis. 🧬
🔗 www.nature.com/articles/s41...
Read more in the latest issue of #EJHG ⬇️
www.nature.com/articles/s41...
Read more in the latest issue of #EJHG ⬇️
www.nature.com/articles/s41...
A unique DNA methylation episignature may help reclassify #VUS and refine diagnosis. 🧬
🔗 www.nature.com/articles/s41...
A unique DNA methylation episignature may help reclassify #VUS and refine diagnosis. 🧬
🔗 www.nature.com/articles/s41...
The November issue explores how #genomic medicine is expanding across healthcare systems, #biobanking, collaborative platforms, and patient-centred perspectives. 🧬
www.nature.com/ejhg/volumes...
The November issue explores how #genomic medicine is expanding across healthcare systems, #biobanking, collaborative platforms, and patient-centred perspectives. 🧬
www.nature.com/ejhg/volumes...
The November issue explores how #genomic medicine is expanding across healthcare systems, #biobanking, collaborative platforms, and patient-centred perspectives. 🧬
www.nature.com/ejhg/volumes...
The November issue explores how #genomic medicine is expanding across healthcare systems, #biobanking, collaborative platforms, and patient-centred perspectives. 🧬
www.nature.com/ejhg/volumes...
#Genetics #PatientSafety
www.nature.com/articles/s41...
#Genetics #PatientSafety
www.nature.com/articles/s41...
➡️ www.nature.com/articles/s41...
➡️ www.nature.com/articles/s41...
➡️ www.nature.com/articles/s41...
➡️ www.nature.com/articles/s41...
www.nature.com/articles/s41...
www.nature.com/articles/s41...
This month, we’re discussing: 'A new multisystem ERCC1-hepatorenal syndrome: insights from a clinical cohort, molecular pathogenesis, and management guidelines'
➡️ www.nature.com/articles/s41...
This month, we’re discussing: 'A new multisystem ERCC1-hepatorenal syndrome: insights from a clinical cohort, molecular pathogenesis, and management guidelines'
➡️ www.nature.com/articles/s41...
This month, we’re discussing: 'A new multisystem ERCC1-hepatorenal syndrome: insights from a clinical cohort, molecular pathogenesis, and management guidelines'
➡️ www.nature.com/articles/s41...
This month, we’re discussing: 'A new multisystem ERCC1-hepatorenal syndrome: insights from a clinical cohort, molecular pathogenesis, and management guidelines'
➡️ www.nature.com/articles/s41...
Most discussed paper of this month: "Genetic influences on antidepressant side effects: a CYP2C19 gene variation and polygenic risk study in the Estonian Biobank" ⬇️
@estbiobank.bsky.social
⬇️⬇️⬇️
www.nature.com/articles/s41...
Most discussed paper of this month: "Genetic influences on antidepressant side effects: a CYP2C19 gene variation and polygenic risk study in the Estonian Biobank" ⬇️
Most discussed paper of this month: "Genetic influences on antidepressant side effects: a CYP2C19 gene variation and polygenic risk study in the Estonian Biobank" ⬇️
@estbiobank.bsky.social
⬇️⬇️⬇️
www.nature.com/articles/s41...
Most discussed paper of this month: "Genetic influences on antidepressant side effects: a CYP2C19 gene variation and polygenic risk study in the Estonian Biobank" ⬇️
📢 Interviews highlight psychosocial impacts and a need for tailored support. @tatyanes.bsky.social
#Genetics #RareDisease ⬇️
www.nature.com/articles/s41...
📢 Interviews highlight psychosocial impacts and a need for tailored support. @tatyanes.bsky.social
#Genetics #RareDisease ⬇️
www.nature.com/articles/s41...
#Genetics #AI #RareDisease ⬇️
www.nature.com/articles/s41...
#Genetics #AI #RareDisease ⬇️
www.nature.com/articles/s41...
www.nature.com/articles/s41...